癌症和 COVID-19 患者的特征和死亡率。
Characteristics and mortality in patients with cancer and COVID-19.
机构信息
Servicio de Neumología y Cirugía de Tórax, Hospital General de México Dr. Eduardo Liceaga.
Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México.
出版信息
Cir Cir. 2024;92(6):769-775. doi: 10.24875/CIRU.23000379.
OBJECTIVE
Throughout the COVID-19 pandemic, care protocols were created to apply in hospital units and care for the vulnerable populationin. The objetive was to describe clini- cal manifestations, comorbidity and mortality in cancer patients with SARS CoV-2 infection, as well as sanitary measures carried out in COVID centers.
METHOD
Retrospective study of 1752 patients admitted to a respiratory care unit.
RESULTS
5% of the population studied had a previous diagnosis of cancer; 59.1% were solid neoplasms and 40.9% hematologic neoplasms. Patients with cancer showed lower rates of admission to the intensive care unit (ICU) compared to patients without cancer (8% vs. 17.4%), with no differences in survival.
CONCLUSIONS
Oncology patients hospitalized with COVID-19 did not have different survival rates and were less likely to require ICU care compared to non-cancer patients, this is likely due to multidisciplinary teamwork during the pandemic.
目的
在 COVID-19 大流行期间，制定了护理规程，以便在医院病房中应用，并为弱势群体提供护理。目的是描述患有 SARS CoV-2 感染的癌症患者的临床症状、合并症和死亡率，以及在 COVID 中心采取的卫生措施。
方法
对 1752 名入住呼吸护理病房的患者进行回顾性研究。
结果
研究人群中 5%有癌症既往诊断；59.1%为实体瘤，40.9%为血液系统肿瘤。与无癌症患者相比，癌症患者入住重症监护病房（ICU）的比例较低（8%比 17.4%），但生存率无差异。
结论
与非癌症患者相比，因 COVID-19 住院的肿瘤患者的生存率没有差异，并且不太需要 ICU 护理，这可能是由于大流行期间多学科团队合作。
Zotero 插件